Vocal fold scars: a common classification proposal by the American Laryngological Association and European Laryngological Society.

American Laryngological Association Benign laryngeal pathology Classification proposal European Laryngological Society Vocal fold scar

Journal

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
ISSN: 1434-4726
Titre abrégé: Eur Arch Otorhinolaryngol
Pays: Germany
ID NLM: 9002937

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 18 05 2019
accepted: 24 05 2019
pubmed: 31 5 2019
medline: 20 11 2019
entrez: 31 5 2019
Statut: ppublish

Résumé

Vocal fold scar is one the most challenging benign laryngeal pathologies. The purpose of this paper is to propose a classification that will allow for a common description of this entity between laryngologists, prevent discrepancies in interpretation, allow for comparison of related studies, and offer a training tool for young laryngologists. Based on the depth and laterality of scarring, we propose 4 types: type I, characterized by atrophy of lamina propria with/without affected epithelium; type II, where the epithelium, lamina propria, and muscle are affected; type III, where the scar is located on the anterior commissure; type IV, which includes extended scar formation in both anteroposterior and rostro-caudal axis with significant loss of vocal fold mass. We believe that our proposal is comprehensive and encompasses all existing iatrogenic and non-iatrogenic etiologies in a simple and concise manner. It also serves its purpose as a descriptive, comparative, and training tool.

Identifiants

pubmed: 31144013
doi: 10.1007/s00405-019-05489-3
pii: 10.1007/s00405-019-05489-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2289-2292

Références

Laryngoscope. 1994 Sep;104(9):1084-91
pubmed: 8072354
Eur Arch Otorhinolaryngol. 2000;257(4):227-31
pubmed: 10867840
Eur Arch Otorhinolaryngol. 2007 May;264(5):499-504
pubmed: 17377801
Ann Otol Rhinol Laryngol. 1983 Mar-Apr;92(2 Pt 1):124-7
pubmed: 6838100
Ann Otol Rhinol Laryngol. 1996 Mar;105(3):189-200
pubmed: 8615582
Nihon Jibiinkoka Gakkai Kaiho. 1974 Sep 20;77(9):650-6
pubmed: 4476746
Otolaryngol Head Neck Surg. 1996 Nov;115(5):474-82
pubmed: 8903451
Eur Arch Otorhinolaryngol. 2013 Sep;270(9):2491-507
pubmed: 23605306

Auteurs

Anastasios Hantzakos (A)

Department of Otolaryngology Head and Neck Surgery, Surgical Subspecialties Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, 112412, UAE. HantzaA@ClevelandClinicAbuDhabi.ae.
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA. HantzaA@ClevelandClinicAbuDhabi.ae.

Frederik G Dikkers (FG)

Department of Otorhinolaryngology, Amsterdam University Medical Center, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.

Antoine Giovanni (A)

Department of Otorhinolaryngology, CHU Conception, Aix-Marseille University, Marseille, France.

Michael S Benninger (MS)

Department of Otolaryngology Head and Neck Surgery, Head and Neck Institute, Cleveland Clinic Lerner College of Medicine, The Cleveland Clinic, 9500 Euclid Avenue, A-71, Cleveland, OH, USA.

Marc Remacle (M)

Department of Otorhinolaryngology Head and Neck Surgery, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg.

Elisabeth V Sjögren (EV)

Department of Otorhinolaryngology Head and Neck Surgery, Leiden University Medical Center, Albinusdreef 2, 2223 RC, Leiden, The Netherlands.

Peak Woo (P)

Department of Otolaryngology Head and Neck Surgery, Icahn School of Medicine at Mount Sinai New York, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH